Repliva 21/7™ is the most prescribed branded oral iron therapy in the U.S.1 Repliva 21/7 is clinically proven to provide efficient iron therapy.2 Just three courses of iron therapy with Repliva 21/7 may result in substantial improvements in patient iron status with less iron than traditional therapy. Repliva 21/7 is formulated for efficient absorption, combining two forms of iron with two absorption promoters in an innovative dosing cycle designed for efficacy, and compliance.

Repliva 21/7™ advantages include:

» Clinically proven efficacy » Requires less iron than traditional therapies » Once-daily dosing » Two forms of iron combined with two absorption promoters » Folic acid and Vitamin B12 to enhance blood cell development » Unique 21/7 dosing cycle